Provenance Record

Well-structured News piece (711 words, within the 400-1200 News range). Clear Overview/What We Know/The Gynecology Filing/What We Don't Know/Analysis sectioning. Technical depth is appropriate and the new regulatory event is correctly foregrounded.

All 4 source snapshots read from disk and verified. source-0 (therobotreport.com): confirms cholecystectomy 510(k) clearance, de novo Oct 2024, commercialization 2026, '40,000+ surgical procedures outside the U.S.', and the verbatim Colella initial-clearance quote 'This 510(k) clearance represents an exciting new chapter for CMR Surgical as we introduce Versius Plus to the U.S. market.' source-1 (medtechdive.com): published Dec. 17, 2025; confirms Dec 17 2025 clearance date, $200M raise, 'second most used systems in the world', and 40,000 procedures. source-2 (medicaldevice-network.com, archive.org fallback): published Dec 17 2025; confirms Dec 17 date, $200m raise, UK and Europe availability, modular design moved between hospital departments, market projection '$9.2bn by 2034, up from $2.9bn in 2024' (GlobalData), over 40,000 procedures, and the verbatim O'Hara quote 'Versius Plus is designed to meet the practical realities of today's healthcare environment — adaptable to different settings, efficient to integrate, and scalable for long-term growth' with title 'president and US general manager'. source-3 (globenewswire.com / CMR release): confirms April 29 2026 510(k) gynecology filing, the procedure list (total hysterectomy, oophorectomy, salpingectomy, other gynecologic procedures), 'cholecystectomy in adult patients 22 years of age and older', 'second most utilized surgical robotic system globally outside of the United States', 5mm-port fully wristed instrumentation, 'over 45,000 patients...treated globally', and the verbatim Colella gynecology quote.

No hallucinations detected. Critically, the two key figures are kept properly separate with no conflation: the '45,000 patients treated' figure appears ONLY in the GlobeNewswire/CMR release (source-3) and the article attributes it solely there; the string '45,000' does not appear in source-0/1/2. The '40,000+ procedures' figure is attributed to The Robot Report (and is independently present in source-1 and source-2) and is never conflated with the 45,000 patient count. The Dec 17 2025 clearance date traces to source-1 (published Dec 17 2025) and source-2 (published Dec 17 2025), exactly as cited; The Robot Report does not carry that specific date and the article does not attribute it there. The April 29 gynecology filing traces to source-3 as cited. The FierceBiotech URL (which 403s and appeared in the earlier April 23 CMR article) is NOT cited in this submission at all.

APPROVE. Every claim, quote, number, name, and date verified against the cited source snapshots; the 45,000 and 40,000 figures are correctly attributed and not conflated; both executive quotes are verbatim; the FierceBiotech 403 source is not cited. The only automated flag is an allowlist gap for two reputable outlets, which is administrative rather than a factual defect — there is nothing a corrections record could honestly inform readers about, so the script's auto-issued APPROVE_WITH_CORRECTIONS is overridden to APPROVE.